Abstract
Successful treatment of GSD by portal diversion was reported with subsequent improvement in growth and return to normal dietary habits. An end-to-side portacaval shunt has been performed in 11 patients aged 7 months to 11 1/2 years (6 with type I and 5 with type III GSD). In 10 patients, patency of the anastomosis was confirmed. In 9 of them, a dramatic improvement of physical activity was observed in spite of persistent hypoglycemia and hyperlactacidemia. Liver size decreased in 7. A threefold decrease in blood cholesterol level (M 164 mg/dl vs. 415 peroperatively) was observed in 8 patients and a tenfold decrease in blood cholesterol level (M 170 mg/dl vs. 1548) in 6 out of 7 tested patients. Uricemia, increased in 4 cases, returned to normal. An increased linear growth rate (M 0.66 cm/month vs. 0.27) was noted in only 5 patients. Two type I patients died, 2 years (thrombosis of the anastomosis) and 6 months (intercurrent infection) after surgery. These results show that the most important benefits of surgery are improvement of general condition and normalization of lipids and uric acid metabolism.
Article PDF
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Odievre, M., Bismuth, H., Douillet, P. et al. Portal diversion in glycogen storage disease (GSD): studies in 11 cases: 20. Pediatr Res 14, 169 (1980). https://doi.org/10.1203/00006450-198002000-00047
Issue Date:
DOI: https://doi.org/10.1203/00006450-198002000-00047